Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
1.530
-0.040 (-2.55%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $550.9 million as of October 9, 2026. Its market cap has decreased by 60.94% in one year.
Market Cap
550.90M
Enterprise Value
562.41M
1-Year Change
-60.94%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $550.90M, a decrease of -94.00%. That is a compound annual growth rate of -43.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 550.90M | -51.54% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | 9.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 719.80M |
| Ironwood Pharmaceuticals | 639.48M |
| Aquestive Therapeutics | 597.44M |
| Evolus | 515.19M |
| Tilray Brands | 491.80M |
| Alpha Teknova | 453.13M |
| Kamada | 440.12M |
| Glass House Brands | 415.61M |